Kawasaki S Disease — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for kawasaki s disease. 17 active patents protecting 1 drugs from 1+ originators. First major cliff: 2027. Daily refresh.

1
Approved drugs
17
Active US patents
55/100
Avg vulnerability
$1.9B
Annual revenue covered

Originators in Kawasaki S Disease

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Novartis AG (originally Sandoz) 17 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating kawasaki s disease. Each bar = one year. Y-axis scaled to peak year (3 patents).

1
27
1
29
1
30
1
31
1
32
3
33
2
34
1
36
3
37
1
38
1
39

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Sandimmune
cyclosporine
 Novartis AG (originally Sandoz) 17 55 $1.9B 2027-11-03

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
12496326 Sandimmune method of use 75 2036-09-29
11951153 Sandimmune method of use 75 2037-02-28
12059449 Sandimmune method of use 75 2042-04-01
11154513 Sandimmune method of use 70 2038-11-20
11413323 Sandimmune method of use 70 2039-10-11
8980839 Sandimmune method of use 62 2033-08-23
9937225 Sandimmune method of use 62 2033-08-23
8614178 Sandimmune formulation 56 2030-12-13
8298568 Sandimmune formulation 55 2027-11-03
10813976 Sandimmune formulation 50 2037-09-22

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10918694 Sandimmune formulation 42 2037-02-28
9669974 Sandimmune formulation 42 2034-05-11
9676525 Sandimmune formulation 42 2034-02-07
10441630 Sandimmune formulation 42 2033-08-23
8561859 Sandimmune formulation 48 2032-04-16
8292129 Sandimmune formulation 48 2031-02-25
9132071 Sandimmune formulation 48 2029-06-02
10813976 Sandimmune formulation 50 2037-09-22
8298568 Sandimmune formulation 55 2027-11-03
8614178 Sandimmune formulation 56 2030-12-13

Related